Danish pharmaceutical company Novo Nordisk has reduced the price of its weight-loss drug, Wegovy, by up to 33% in India. This price cut follows the rise of Eli Lilly's Mounjaro as the top-selling ...

This article was reviewed by Darragh O’Carroll, MD. Semaglutide Side Effects: What to Know Key takeaways: Common semaglutide ...

Danish drugmaker Novo Nordisk on Tuesday cut the price of its blockbuster weight-loss drug, Wegovy, by up to 33% in India, ...

‘Both GLP-1s and exercise can have significant, but somewhat different, impacts on cardiovascular health. Large trials of GLP-1s have shown clear cardiovascular benefits in people who already have ...

Dr. Paras Agarwal said weight loss drugs like Mounjaro and Wegovy are for those at health risk from obesity, and lifestyle ...

After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them ...

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them more affordable and accessible ...

GLP-1 drugs manufactured by Eli Lily and Novo Nordisk will cost as much as $350 per month for eligible patients.

Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone amylin that slows digestion and reduces hunger.

Novo Nordisk A/S posted solid revenue and profit increases, with a resilient pipeline and strong dividend yield. Learn more ...